RDMD

RDMD is a privately held medical data science company headquartered in San Francisco, California. The company employs 21 individuals and generates approximately $50 million in annual revenue. RDMD specializes in identifying patients and generating regulatory-grade evidence for the development of treatments for rare diseases. Their services assist in obtaining drug approvals and generating real-world evidence in the field of rare disease research. RDMD's mission is to empower patients and communities to accelerate the development of treatments for rare diseases of all kinds. The company is privately funded by Lux Capital and Village Global, a venture capital firm with a network of prominent investors. For more information about RDMD's mission and services, please visit their website at www.rdmd.com.